JP2002513156A5 - - Google Patents

Download PDF

Info

Publication number
JP2002513156A5
JP2002513156A5 JP2000546239A JP2000546239A JP2002513156A5 JP 2002513156 A5 JP2002513156 A5 JP 2002513156A5 JP 2000546239 A JP2000546239 A JP 2000546239A JP 2000546239 A JP2000546239 A JP 2000546239A JP 2002513156 A5 JP2002513156 A5 JP 2002513156A5
Authority
JP
Japan
Prior art keywords
phage display
library
internalized
display library
target cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000546239A
Other languages
English (en)
Japanese (ja)
Other versions
JP4493845B2 (ja
JP2002513156A (ja
Filing date
Publication date
Priority claimed from US09/249,529 external-priority patent/US6794128B2/en
Application filed filed Critical
Publication of JP2002513156A publication Critical patent/JP2002513156A/ja
Publication of JP2002513156A5 publication Critical patent/JP2002513156A5/ja
Application granted granted Critical
Publication of JP4493845B2 publication Critical patent/JP4493845B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000546239A 1998-04-24 1999-04-22 インターナライズする抗体を選択する方法 Expired - Fee Related JP4493845B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8295398P 1998-04-24 1998-04-24
US60/082,953 1998-04-24
US09/249,529 1999-02-12
US09/249,529 US6794128B2 (en) 1998-04-24 1999-02-12 Methods of selecting internalizing antibodies
PCT/US1999/008468 WO1999056129A1 (en) 1998-04-24 1999-04-22 Methods of selecting internalizing antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009170482A Division JP2009278993A (ja) 1998-04-24 2009-07-21 インターナライズする抗体を選択する方法

Publications (3)

Publication Number Publication Date
JP2002513156A JP2002513156A (ja) 2002-05-08
JP2002513156A5 true JP2002513156A5 (https=) 2006-05-25
JP4493845B2 JP4493845B2 (ja) 2010-06-30

Family

ID=26768026

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000546239A Expired - Fee Related JP4493845B2 (ja) 1998-04-24 1999-04-22 インターナライズする抗体を選択する方法
JP2009170482A Pending JP2009278993A (ja) 1998-04-24 2009-07-21 インターナライズする抗体を選択する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009170482A Pending JP2009278993A (ja) 1998-04-24 2009-07-21 インターナライズする抗体を選択する方法

Country Status (8)

Country Link
US (3) US6794128B2 (https=)
EP (1) EP1073905B1 (https=)
JP (2) JP4493845B2 (https=)
AT (1) ATE525385T1 (https=)
AU (1) AU768784B2 (https=)
CA (1) CA2326499C (https=)
DK (1) DK1073905T3 (https=)
WO (1) WO1999056129A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7853411B2 (en) * 1997-02-27 2010-12-14 Cellomics, Inc. System for cell-based screening
IL140918A0 (en) 1998-07-27 2002-02-10 Genentech Inc Improved transformation efficiency in phage display through modification of a coat protein
US7563874B2 (en) * 1998-08-31 2009-07-21 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US7780882B2 (en) * 1999-02-22 2010-08-24 Georgetown University Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
ATE511543T1 (de) * 1999-02-22 2011-06-15 Univ Georgetown Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung
US9034329B2 (en) * 1999-02-22 2015-05-19 Georgetown University Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
WO2000052054A2 (en) 1999-03-01 2000-09-08 Genentech, Inc. Antibodies for cancer therapy and diagnosis
US7045283B2 (en) * 2000-10-18 2006-05-16 The Regents Of The University Of California Methods of high-throughput screening for internalizing antibodies
WO2002048403A2 (en) * 2000-12-11 2002-06-20 Hk Pharmaceuticals, Inc. Multiplexed protein expression and activity assay
ES2430857T3 (es) 2000-12-18 2013-11-22 Dyax Corp. Bibliotecas focalizadas de paquetes genéticos
US20030104402A1 (en) * 2001-01-23 2003-06-05 University Of Rochester Methods of producing or identifying intrabodies in eukaryotic cells
AU2002258480B2 (en) * 2001-03-07 2007-03-15 Xenogen Corporation Methods of screening for introduction of DNA into a target cell
US20030194798A1 (en) * 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
ITRM20010408A1 (it) 2001-07-10 2003-01-10 Univ Napoli Federico Ii Mini-anticorpo umano citotossico per cellule tumorali che esprimono il recettore erbb2.
US20030073104A1 (en) * 2001-10-02 2003-04-17 Belcher Angela M. Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
AU2002351353A1 (en) * 2001-12-19 2003-09-02 Genentech, Inc. Stabilizing polypeptides which have been exposed to urea
US7332580B2 (en) * 2002-04-05 2008-02-19 The Regents Of The University Of California Bispecific single chain Fv antibody molecules and methods of use thereof
US7332585B2 (en) 2002-04-05 2008-02-19 The Regents Of The California University Bispecific single chain Fv antibody molecules and methods of use thereof
GB2392723B (en) 2002-09-04 2005-01-12 Bioinvent Int Ab Screening methods
US20050064508A1 (en) * 2003-09-22 2005-03-24 Semzyme Peptide mediated synthesis of metallic and magnetic materials
US9701754B1 (en) * 2002-10-23 2017-07-11 City Of Hope Covalent disulfide-linked diabodies and uses thereof
CA2558758C (en) * 2004-02-24 2015-06-23 Allergan, Inc. Botulinum toxin screening assays
US7700738B2 (en) * 2005-01-27 2010-04-20 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
MX2007013200A (es) * 2005-04-22 2008-03-24 Johnson & Johnson Composicion de inmunoliposoma para el direccionamiento hacia un receptor de la celula her2.
MX2008014362A (es) * 2006-05-15 2008-11-27 Univ Georgetown Preparacion de inmunoliposomas dirigidos a anticuerpos o a fragmentos de anticuerpos para la administracion sistemica de agentes terapeuticos o de diagnostico y usos de los mismos.
WO2008040348A2 (en) * 2006-10-03 2008-04-10 Genmab A/S High througput methods for characterization of antibodies
US20100104572A1 (en) * 2006-11-02 2010-04-29 Sylvie Luria Methods for screening for therapeutic molecules and use of the molecules therefrom
AU2007353412A1 (en) * 2006-11-21 2008-11-20 Fox Chase Cancer Center Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
CA2680741A1 (en) 2007-03-22 2009-01-15 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
US20090175784A1 (en) 2007-05-11 2009-07-09 Joshua Goldstein Anti-Alpha V Immunoliposome Composition, Methods, and Uses
WO2009009054A1 (en) * 2007-07-09 2009-01-15 Georgetown University Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery
WO2010014854A2 (en) 2008-07-31 2010-02-04 The Regents Of The University Of California Antibodies that neutralize botulinum neurotoxins
CN102395603A (zh) * 2008-12-26 2012-03-28 国立大学法人东京大学 使用抗lgr7抗体的癌症的诊断和治疗
US8609095B2 (en) 2010-03-04 2013-12-17 Symphogen A/S Anti-HER2 antibodies and compositions
JP6039428B2 (ja) * 2010-03-04 2016-12-07 シムフォゲン・アクティーゼルスカブＳｙｍｐｈｏｇｅｎ Ａ／Ｓ 抗ｈｅｒ２抗体および組成物
US9243057B2 (en) 2010-08-31 2016-01-26 The Regents Of The University Of California Antibodies for botulinum neurotoxins
EP2675918B1 (en) 2011-02-15 2017-11-08 Merrimack Pharmaceuticals, Inc. Compositions and methods for delivering nucleic acid to a cell
GB201116364D0 (en) 2011-09-22 2011-11-02 Bioinvent Int Ab Screening methods and uses thereof
US9097721B2 (en) 2012-02-29 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions comprising engineered phosphothreonine affinity reagents, methods of making, and methods of use
ES2920601T3 (es) 2013-06-28 2022-08-05 X Body Inc Descubrimiento de antígenos objetivo, cribados fenotípicos y uso de los mismos para la identificación de epítopos objetivo específicos de células objetivo
WO2015042528A1 (en) * 2013-09-23 2015-03-26 X-Body Biosciences, Inc. Methods and compositions for generation of binding agents against cell surface antigens
CN104894652A (zh) * 2015-06-25 2015-09-09 黄薇 一种cTnI人源化单链抗体库的构建及应用
CN105273084B (zh) * 2015-09-25 2018-10-09 中国人民解放军第四军医大学 靶向HER2的人源化改造的非内化单链抗体P2h2及应用
CA3026236C (en) * 2016-06-03 2021-01-26 Samsung Life Public Welfare Foundation Method for screening antibody using patient-derived tumor spheroids
EP3475700A4 (en) 2016-06-26 2020-03-04 Gennova Biopharmaceuticals Limited Antibody phage display library
EP3717682A4 (en) 2017-11-30 2021-09-01 University of Delhi, South Campus LIBRARY OF ANTIBODY FRAGMENTS AND ITS USES
CN111629715A (zh) 2018-01-18 2020-09-04 弗莱德哈钦森癌症研究中心 通过调节细胞活化状态改变体内免疫细胞的炎症状态
NL2038054B1 (en) 2024-06-25 2026-01-15 Academisch Ziekenhuis Leiden A method for preparing liposomes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892827A (en) 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
US5242824A (en) * 1988-12-22 1993-09-07 Oncogen Monoclonal antibody to human carcinomas
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
WO1994026787A1 (en) * 1993-05-07 1994-11-24 The Board Of Trustees Of The Leland Stanford Junior University Method for generating cell type specific phage antibody libraries
US5733782A (en) 1993-10-25 1998-03-31 Creative Biomolecules, Inc. Methods and compositions for high protein production from non-native DNA
US5736388A (en) * 1994-12-30 1998-04-07 Chada; Sunil Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
SE9503151D0 (sv) 1995-09-13 1995-09-13 Bioinvent Internatioal Ab Combined ligand and receptor display
CA2251738A1 (en) * 1996-04-16 1997-10-23 Immusol Incorporated Targeted viral vectors
AU3737297A (en) * 1996-08-05 1998-02-25 Brigham And Women's Hospital Bacteriophage-mediated gene therapy
US6057098A (en) * 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors

Similar Documents

Publication Publication Date Title
JP2002513156A5 (https=)
US5629156A (en) Multiple capture probe sandwich assays
AU702125B2 (en) Immunoassay and kit with two reagents that are cross-linked if they adhere to an analyte
US20160102344A1 (en) Site-Specific Immobilization of DNA Origami Structures on Solid Substrates
EP2290100A8 (en) Kits for displacement Sandwich Immuno-PCR
JP2023505195A (ja) 核酸結合免疫サンドイッチアッセイ（ｎｕｌｉｓａ）
JP2003527832A5 (https=)
JP2006502416A5 (https=)
JPH05508074A (ja) インビトロにおける増幅を用いたポリヌクレオチド捕捉アッセイ
JP2004531270A5 (https=)
JP2008532485A5 (https=)
JP2010509914A5 (https=)
JP2010508513A5 (https=)
WO1997044469A8 (en) Multiple epitope fusion protein
JP2008503720A5 (https=)
CN103559017B (zh) 基于gpu异构计算平台的字符串匹配方法及系统
JP2019512224A5 (https=)
CA2406240A1 (en) Hcv anti-core monoclonal antibodies
JP2005521411A5 (https=)
CN110579591A (zh) 一种检测石斑鱼神经坏死病毒的胶体金试纸条及其制备和检测方法
Li et al. Quantitative PCR is a valuable tool to monitor the performance of DNA‐encoded chemical library selections
JPS60185798A (ja) ウイルス粒子中のｄｎａ又はｒｎａの抽出方法、該方法に基づく検定法及び該方法で使用するキツト
Burgahn et al. Solid‐Phase Synthesis and Purification of Protein–DNA Origami Nanostructures
CN104531853A (zh) 经高密度纳米点阵列制备生物大分子单分子芯片的方法
CN106337053B (zh) 一种用于鲤春病毒血症病毒检测的核酸适配体及其应用